Recent research ties neurological diseases to the coronavirus 2019 (COVID-19) pandemic, a condition that has disrupted our lives and made our planet a different one from December 2019 to today. It is a unique kind of human coronavirus that has been identified as the causative agent of SARS-CoV-2 and has been reported for the first time in Wuhan, China. COVID-19 infection, according to new research, can aggravate the clinical spectrum of exhibited neurological illnesses. Recent studies, on the other hand, have brought the possible significance of this novel coronavirus in the future development of neurological diseases into the forefront, making the neurobiological relationship between these two conditions even more intriguing. Confinement, which may lead to social isolation, is one of the social consequences of the Covid-19's impact on neurodegenerative disorders.
- COVID-19 And Mental Health
- Lockdown and Its Effects
- Telemedicine
- Medicines and Therapies
Jacqueline Tuppen
Cogs Club, United Kingdom
Kaoru Sakatani
The University of Tokyo, Japan
Marco Orsini
Rio De Janeiro State University, BrazilSubmit your abstract Today
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Him, that person and me
Simon C Barton, Stroke Survivor, United States
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States